Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Qiu, Jinlang ^a   Wang, Wenjing ^a   Wu, Jingbo ^a   Zhang, Hui ^b   Wang, Yuanzhi ^b   Qiao, Jun ^b   Chen, Chuangfu ^b   Gao, Goege F ^c   Allain, Jean Pierre ^a,d   Li, Chengyao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCELLA VACCINE; EPITOPE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PERIPLASMIC PROTEIN; PROTEIN BP26; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BP26 PROTEIN, BRUCELLA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; BRUCELLA MELITENSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PROTEIN CONFORMATION; PROTEIN MOTIF; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHEEP; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; IMMUNOLOGY; MOLECULAR GENETICS;

BRUCELLA MELITENSIS; CAPRA HIRCUS; MURINAE; OVIS ARIES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BRUCELLA MELITENSIS; EPITOPES; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; SHEEP;

EID: 84863362073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034246     Document Type: Article

References (33)

1. World Health Organization (1997) Fact Sheet N173. July 1997, Geneva, Switzerland.
2. Deqiu S, Donglou X, Jiming Y, (2002) Epidemiology and control of brucellosis in China. Vet Microbiol 90: 165-182.
3. Chinese Center for Disease Control and Prevention (2011) Chinese Health Statistical Digest 2010: Number of reported incidence and death of 28 infectious diseases in 2009. March 4, 2011, Beijing, China.
4. Zhang WY, Guo WD, Sun SH, Jiang JF, Sun HL, et al. (2010) Human brucellosis, Inner Mongolia, China. Emerg Infect Dis 16: 2001-2003.
5. Cloeckaert A, Debbarh HS, Vizcaino N, Saman E, Dubray G, et al. (1996) Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol Lett 140: 139-144.
6. Rossetti OL, Arese AI, Boschiroli ML, Cravero SL, (1996) Cloning of Brucella abortus gene and characterization of expressed 26-kDa periplasmic protein: potential use for diagnosis. J Clin Microbiol 34: 165-169.
7. Salih-Alj, Debbarh H, Cloeckaert A, Bezard G, Dubray G, et al. (1996) Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kDa protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep. Clin Diagn Lab Immunol 3: 305-308.
8. Cloeckaert A, Baucheron S, Vizcaino N, Zygmunt MS, (2001) Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep. Clin Diagn Lab Immunol 8: 772-775.
9. Gupta VK, Kumari R, Vohra J, Singh SV, Vihan VS, (2010) Comparative evaluation of recombinant BP26 protein for serological diagnosis of Brucella melitensis infection in goats. Small Ruminant Research 93: 119-125.
10. Seco-Mediavilla P, Verger JM, Grayon M, Cloeckaert A, Marín CM, et al. (2003) Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis. Clin Diagn Lab Immunol 10: 647-651.
11. Clapp B, Walters N, Thornburg T, Hoyt T, Yang X, et al. (2011) DNA vaccination of bison to brucellar antigens elicits elevated antibody and IFN-γ responses. J Wildl Dis 47: 501-510.
12. Yang X, Hudson M, Walters N, Bargatze RF, Pascual DW, (2005) Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun 73: 7297-7303.
13. Yang X, Walters N, Robison A, Trunkle T, Pascual DW, (2007) Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine 25: 2261-2268.
14. Blasco JM, (1997) A review of the use of B. melitensis Rev1 vaccine in adult sheep and goats. Prev Vet Med 31: 275-283.
15. Elberg SS, Faunce JrK, (1957) Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis. J Bacteriol 73: 211-217.
16. Garin-Bastuji B, Blasco JM, Grayon M, Verger JM, (1998) Brucella melitensis infection in sheep: present and future. Vet Res 29: 255-274.
17. Research Group of Brucellosis of Harbin Veterinary Research Institute (1991) Study on the Brucella melitensis strain M5-90 vaccine. Chinese J Control Endemic Dis 6: 65-68.
18. Blasco JM, Diaz R, (1993) Brucella melitensis Rev.1 vaccine as a cause of human brucellosis. Lancet 342: 805.
19. Ficht TA, Kahl-McDonagh MM, Arenas-Gamboa AM, Rice-Ficht AC, (2009) Brucellosis: the case for live, attenuated vaccines. Vaccine 27: D40-43.
20. Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, et al. (2004) Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22: 2827-2835.
21. Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, et al. (2009) Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams. Vaccine 27: 187-191.
22. Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, et al. (2007) Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep. Vaccine 25: 794-805.
23. Qu Q, Wang ZJ, Zhen Q, Huang LY, Yu YQ, et al. (2009) Effect of bp26 on immune response and protective efficacy of M 5 against Brucella melitensis in mice. Journal of Jilin Agricultural University 31: 438-446.
24. Wang ZJ, Zhen Q, Qiao F, Wang YF, Du XY, et al. (2009) Construction of BP26 tagged vaccine strain and development of discriminating PCR for Brucella. Acta Microbiologica Sinica 49: 405-409.
25. Vizcaíno N, Cloeckaert A, Zygmunt MS, Dubray G, (1996) Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein. Infect Immun 64: 3744-3751.
26. Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, et al. (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73: 8079-8088.
27. Cassataro J, Velikovsky CA, de la Barrera S, Estein SM, Bruno L, et al. (2005) A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun 73: 6537-6546.
28. Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, et al. (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77: 436-445.
29. Liu WX, Hu S, Qiao ZJ, Chen WY, Liu LT, et al. (2011) Expression, purification, and improved antigenic specificity of a truncated recombinant bp26 protein of Brucella melitensis M5-90: a potential antigen for differential serodiagnosis of brucellosis in sheep and goats. Biotechnol Appl Biochem 58: 32-38.
30. Salih-Alj, Debbarh H, Zygmunt MS, Dubray G, Cloeckaert A, (1996) Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep. Vet Microbiol 53: 325-337.
31. Molloy MP, Herbert BR, Slade MB, Rabilloud T, Nouwens AS, et al. (2000) Proteomic analysis of the Escherichia coli outer membrane. Eur J Biochem 267: 2871-2881.
32. Li C, Candotti D, Allain JP, (2001) Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol 75: 12412-12420.
33. Ndongo N, Berthillon P, Pradat P, Vieux C, Bordes I, et al. (2010) Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus. Hepatology 52: 1531-1542.